Suppression of a pro-apoptotic K+channel as a mechanism for hepatitis C virus persistence
- 15 September 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (37) , 15903-15908
- https://doi.org/10.1073/pnas.0906798106
Abstract
An estimated 3% of the global population are infected with hepatitis C virus (HCV), and the majority of these individuals will develop chronic liver disease. As with other chronic viruses, establishment of persistent infection requires that HCV-infected cells must be refractory to a range of pro-apoptotic stimuli. In response to oxidative stress, amplification of an outward K+current mediated by the Kv2.1 channel, precedes the onset of apoptosis. We show here that in human hepatoma cells either infected with HCV or harboring an HCV subgenomic replicon, oxidative stress failed to initiate apoptosis via Kv2.1. The HCV NS5A protein mediated this effect by inhibiting oxidative stress-induced p38 MAPK phosphorylation of Kv2.1. The inhibition of a host cell K+channel by a viral protein is a hitherto undescribed viral anti-apoptotic mechanism and represents a potential target for antiviral therapy.Keywords
This publication has 38 references indexed in Scilit:
- The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic functionThe International Journal of Biochemistry & Cell Biology, 2009
- HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA MicePLoS Pathogens, 2009
- Hepatitis C Virus Neuroinvasion: Identification of Infected CellsJournal of Virology, 2009
- Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channelHepatology, 2008
- Alterations in intracellular potassium concentration by HIV-1 and SIV NefVirology Journal, 2008
- Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1Proceedings of the National Academy of Sciences, 2007
- Global epidemiology of hepatitis C virus infectionPublished by Elsevier ,2005
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- Hepatitis C virus NS5A: tales of a promiscuous proteinJournal of General Virology, 2004